首页> 外文期刊>Medicine. >Efficacy and safety of traditional Chinese medicine decoction combined with chemotherapy in the treatment of advanced colorectal cancer
【24h】

Efficacy and safety of traditional Chinese medicine decoction combined with chemotherapy in the treatment of advanced colorectal cancer

机译:中药汤剂联合化疗治疗晚期结直肠癌的疗效和安全性

获取原文
       

摘要

BACKGROUND:Colorectal cancer has become a major chronic and difficult disease endangering human health. After thousands of years of precipitation, traditional Chinese medicine in China is now also being applied in clinical treatment, with its unique advantages in the treatment of cancer. However, the efficacy of traditional Chinese medicine in the treatment of advanced colorectal cancer still cannot reach consensus in the world. Therefore, the aim of this study was to provide a scheme to evaluate the efficacy and safety of traditional Chinese medicine decoction in the treatment of advanced colorectal cancer, thus providing clinical decision-making.METHODS AND ANALYSIS:The systematic review and meta-analysis will be conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. The following 8databases will be searched: China National Knowledge Infrastructure (CNKI), China Biology Medicine (CBM), Wan Fang Data, the Chinese Science and Technology Periodical Database (VIP), PubMed, Cochrane Library, Embase, and Web of Science. Relevant data will be performed by Revman 5.3 software provided (Cochrane Collaboration) and Stata 14.0 statistical software.RESULTS:The results of this systematic review and meta-analysis will be published in a peer-reviewed journal.INPLASY REGISTRATION NUMBER:INPLASY202080102.Copyright ? 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
机译:背景:结直肠癌已成为危及人类健康的主要慢性和困难疾病。经过数千年的降水,中国中药现在也在临床治疗中应用,具有独特的癌症优势。然而,中医在治疗晚期结直肠癌中的疗效仍无法在世界上达成共识。因此,本研究的目的是提供一种评估中药汤治疗晚期结直肠癌治疗中的疗效和安全性的方案,从而提供临床决策。方法和分析:系统审查和荟萃分析将会按照优选的报告项目进行系统审查和荟萃分析(PRISMA)指南进行。将搜索以下8个Databases:中国国家知识基础设施(CNKI),中国生物医学(CBM),万芳数据,中国科学和技术定期数据库(VIP),PubMed,Cochrane图书馆,Embase和科学网。 Revman 5.3提供的相关数据2021提交人。由Wolters Kluwer Health,Inc。出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号